SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-004230
Filing Date
2021-11-12
Accepted
2021-11-12 07:18:10
Documents
13
Period of Report
2021-11-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20211112.htm   iXBRL 8-K 64380
2 EX-99.1 acet-ex99_1.htm EX-99.1 20511
  Complete submission text file 0000950170-21-004230.txt   221553

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20211112.xsd EX-101.SCH 2495
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20211112_pre.xml EX-101.PRE 11504
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20211112_lab.xml EX-101.LAB 19138
6 EXTRACTED XBRL INSTANCE DOCUMENT acet-20211112_htm.xml XML 4877
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 211399541
SIC: 2834 Pharmaceutical Preparations